Public-registry trials using Cyclophosphamide that Eichor's radar has found — 2 trials. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6). | AstraZeneca | Newly Diagnosed Multiple Myeloma (NDMM) | PHASE3 | 65 |
| TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia | TCR2 Therapeutics | Non Hodgkin Lymphoma | PHASE1 / PHASE2 | 3 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →